CCL2 and early-onset autosomal dominant Alzheimer disease: One possible explanation for this is that amyloid plaques in this Alzheimer’s disease mouse model are more abundant in the cortex than in the hippocampus [52], which could explain why MCP-1 levels were significantly increased in the brain cortex but not in the hippocampus of APP/PS1 mice.